Autoimmune encephalomyelitis ameliorated by AMPA antagonists
- PMID: 10613825
- DOI: 10.1038/71548
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Abstract
Multiple sclerosis is an immune-mediated disorder of the central nervous system leading to progressive decline of motor and sensory functions and permanent disability. The therapy of multiple sclerosis is only partially effective, despite anti-inflammatory, immunosuppresive and immunomodulatory measures. White matter inflammation and loss of myelin, the pathological hallmarks of multiple sclerosis, are thought to determine disease severity. Experimental autoimmune encephalomyelitis reproduces the features of multiple sclerosis in rodents and in nonhuman primates. The dominant early clinical symptom of acute autoimmune encephalomyelitis is progressive ascending muscle weakness. However, demyelination may not be profound and its extent may not correlate with severity of neurological decline, indicating that targets unrelated to myelin or oligodendrocytes may contribute to the pathogenesis of acute autoimmune encephalomyelitis. Here we report that within the spinal cord in the course of autoimmune encephalomyelitis not only myelin but also neurons are subject to lymphocyte attack and may degenerate. Blockade of glutamate AMPA receptors ameliorated the neurological sequelae of autoimmune encephalomyelitis, indicating the potential for AMPA antagonists in the therapy of multiple sclerosis.
Comment in
-
Multiple approaches to multiple sclerosis.Nat Med. 2000 Jan;6(1):15-6. doi: 10.1038/71466. Nat Med. 2000. PMID: 10613811 No abstract available.
Similar articles
-
Multiple sclerosis and glutamate.Ann N Y Acad Sci. 2003 May;993:229-75; discussion 287-8. doi: 10.1111/j.1749-6632.2003.tb07533.x. Ann N Y Acad Sci. 2003. PMID: 12853317
-
Glutamate excitotoxicity in a model of multiple sclerosis.Nat Med. 2000 Jan;6(1):67-70. doi: 10.1038/71555. Nat Med. 2000. PMID: 10613826
-
Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?J Neural Transm Suppl. 2000;(60):375-85. doi: 10.1007/978-3-7091-6301-6_27. J Neural Transm Suppl. 2000. PMID: 11205156
-
The link between excitotoxic oligodendroglial death and demyelinating diseases.Trends Neurosci. 2001 Apr;24(4):224-30. doi: 10.1016/s0166-2236(00)01746-x. Trends Neurosci. 2001. PMID: 11250007 Review.
-
[Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].Postepy Hig Med Dosw (Online). 2006;60:571-83. Postepy Hig Med Dosw (Online). 2006. PMID: 17115007 Review. Polish.
Cited by
-
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.
-
P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.J Neurosci. 2007 Aug 29;27(35):9525-33. doi: 10.1523/JNEUROSCI.0579-07.2007. J Neurosci. 2007. PMID: 17728465 Free PMC article.
-
Glutamate antagonists: deadly liaisons with cancer.Proc Natl Acad Sci U S A. 2001 May 22;98(11):5947-8. doi: 10.1073/pnas.121179198. Proc Natl Acad Sci U S A. 2001. PMID: 11371628 Free PMC article. No abstract available.
-
G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis.Sci Adv. 2022 Aug 5;8(31):eabm5500. doi: 10.1126/sciadv.abm5500. Epub 2022 Aug 5. Sci Adv. 2022. PMID: 35930635 Free PMC article.
-
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.J Exp Med. 2008 Oct 27;205(11):2473-81. doi: 10.1084/jem.20081241. Epub 2008 Oct 6. J Exp Med. 2008. PMID: 18838545 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
